Prawo i regulacje · 05/03/1996

DEA Proposes Regulatory Overhaul to Clarify and Streamline Pharmaceutical Regulations

The Drug Enforcement Administration (DEA) has proposed amendments to the Code of Federal Regulations to address areas of confusion in pharmaceutical, chemical, and healthcare industries, as part of the President's National Performance Review and Regulatory Reinvention Initiative.